LEADER 05179nam 2200625 450 001 9910460918103321 005 20191011094745.0 010 $a1-910190-04-7 035 $a(CKB)3710000000355112 035 $a(EBL)1977391 035 $a(SSID)ssj0001466834 035 $a(PQKBManifestationID)11831245 035 $a(PQKBTitleCode)TC0001466834 035 $a(PQKBWorkID)11504597 035 $a(PQKB)10032986 035 $a(MiAaPQ)EBC1977391 035 $a(MiAaPQ)EBC5897829 035 $a(Au-PeEL)EBL5897829 035 $a(OCoLC)904518280 035 $a(EXLCZ)993710000000355112 100 $a20191011d2015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAdvanced vaccine research $emethods for the decade of vaccines /$fedited by Fabio Bagnoli and Rino Rappuoli 210 1$aNorfolk, England :$cCaister Academic Press,$d[2015] 210 4$d©2015 215 $a1 online resource (474 p.) 300 $aDescription based upon print version of record. 311 $a1-910190-03-9 320 $aIncludes bibliographical references and index. 327 $aContents; Contributors; Current Books of Interest; Preface; Part I: Innovative Technologies and Approaches in Vaccine Research; 1: Deep Sequencing in Vaccine Research, Development and Surveillance ; Impact of DNA sequencing on vaccines research and development; Deep sequencing potential to transform vaccinology; 2: New Bioinformatics Algorithms Applied to Deep Sequencing Projects ; Introduction; Better understating of host and pathogen genomes; Computational approaches to study adaptive immune responses; Better understanding of transcriptome 327 $aEpigenomics: understanding of inheritable chemical changesMetagenomics: finding new pathogens and strains; Bioinformatics challenges; 3: Comparative Genomics Approaches for Tracking the Emergence and Spread of Disease-associated Bacteria; Background; Comparative genomics of disease-associated bacteria; Assays for identification of disease-associated bacteria based on insights from comparative genomics; Conclusions; 4: Quantitative Proteomics in Vaccine Research; Introduction; Quantitative proteomics based on gel electrophoresis; Quantitative proteomics based on differential mass tag 327 $aLabel-free technologies and targeted proteomicsMass spectrometry for viral vaccinology; Proteomic technology for vaccine development ; Combining proteomics and system biology to improve vaccines; Concluding remarks; 5: Structural Biology in Vaccine Research; Introduction; Experimental mapping and computational prediction of epitopes; Examples of structural vaccinology for bacterial and viral pathogens; Concluding remarks and future directions; 6: Cellular Screens to Interrogate the Human T- and B-cell Repertoires and Design Better Vaccines ; Introduction 327 $aGeneration of naive B- and T-cell repertoires7: Novel Strategies of Vaccine Administration: The Science Behind Epidermal and Dermal Immunization; Introduction; The skin layers; Skin antigen-presenting cells and other players in vaccination; Principles and methods in skin immunization; Vaccine formulation and immunity; Immunological advantage of epidermal and dermal immunization; 8: Toll-like Receptors as Targets to Develop Novel Adjuvants; Introduction; Innate immunity; TLR-based adjuvants in high-priority vaccines; Lessons learned from studies of TLR agonists as adjuvants 327 $aSafety considerations of TLR agonistsChallenges for the next decade; 9: The Importance of Cell-mediated Immunity for Bacterial Vaccines ; Introduction; T-cell responses to bacterial infection; Targeting cellular immunity for novel anti-bacterial vaccine design; 10: T-cell-inducing Vaccines; Introduction; How can we measure T-cell responses?; Technologies for inducing T-cell responses by vaccination; Heterologous prime-boost immunization; Successful clinical development of T-cell vaccines; 11: Exploiting the Mutanome for Personalized Cancer Immunotherapy 327 $aCancer mutations as therapeutic targets 330 $aSince the publication of our first book book ""Vaccine Design: Innovative Approaches and Novel Strategies"" in 2011, the field of vaccinology has advanced significantly. The application of new sophisticated 'omics' technologies and the use of pioneering approaches have yielded a wealth of new data. This new book aims to distill the most important new findings to provide a timely overview of the field. Written by leading experts in the field, each chapter affords a critical insight to a particular topic, reviews current research, discusses future direction and aims to stimulate discussion. The 606 $aVaccines$xResearch 606 $aDrug development 608 $aElectronic books. 615 0$aVaccines$xResearch. 615 0$aDrug development. 676 $a615.372 702 $aBagnoli$b Fabio 702 $aRappuoli$b Rino 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910460918103321 996 $aAdvanced vaccine research$92229886 997 $aUNINA LEADER 01466nam a22003011i 4500 001 991003158349707536 005 20040622155213.0 008 040624s1986 gr a||||||||||||||||fre 035 $ab13032550-39ule_inst 035 $aARCHE-099023$9ExL 040 $aDip.to Beni Culturali$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a726 245 00$aTenos 1 :$ble sanctuaire de Poseidon et d'Amphitrite /$cpar Roland Etienne et Jean-Pierre Braun ; avec un appendice de François Queyrel 260 $aAthenes :$bÉcole française d'Athenes,$c1986 300 $a3 v. :$bill. ;$c29 cm 440 0$aBibliothèque des écoles françaises d'Athènes et de Rome ;$v263 650 4$aTenos$xSantuario di Poseidone e di Anfitrite 700 1 $aÉtienne, Roland 700 1 $aBraun, Jean Pierre$eauthor$4http://id.loc.gov/vocabulary/relators/aut$0223427 700 1 $aQueyrel, François 907 $a.b13032550$b02-04-14$c12-07-04 912 $a991003158349707536 945 $aLE001 AR IX 47$g1$i2001000131020$lle001$nV. 1. - C. 1$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i13648792$z12-07-04 945 $aLE001 AR IX 47a$g1$i2001000131037$lle001$nV. 2. - C. 1$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i13648809$z12-07-04 945 $aLE001 AR IX 47b$g1$i2001000129331$lle001$nV. 3. - C. 1$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i13648810$z12-07-04 996 $aTenos 1$91449820 997 $aUNISALENTO 998 $ale001$b12-07-04$cm$da $e-$ffre$ggr $h0$i3